Universe Pharmaceuticals INC Dossier
Qualitative Analysis
Business overview
Universe Pharmaceuticals INC (NASDAQ: UPC) is a specialty pharmaceutical company headquartered in Ji'An, Jiangxi Province, China. Founded in 1998, the company specializes in the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivatives (TCMD) products. Its proprietary product portfolio is primarily tailored to elderly consumers, focusing on the treatment and relief of common chronic health conditions (such as Guben Yanling Pill, Shenrong Weisheng Pill, and Quanlu Pill) as well as cold and flu medications. In addition to its own manufactured TCMDs, the company operates a commercial trade business through its subsidiary, Jiangxi Universe Pharmaceuticals Commercial Trade Co., Ltd. (Universe Trade), distributing third-party biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements.
Research as of 20 Jun 2026
Strategic Initiatives
Growth programs, investments, and their expected impact
Expanding brand awareness of traditional Chinese medicine derivatives (TCMD) from Southern China (especially Jiangxi Province) to other parts of China to achieve national recognition.
Expected impact: Mitigates regional concentration risks and drives long-term sustainable sales growth across multiple provinces.
Broadening the product portfolio by distributing third-party biomedical drugs, medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements alongside proprietary TCMD products.
Expected impact: Reduces dependency on a single product line and captures a larger share of the elderly healthcare market.
Mergers, Acquisitions & Partnerships
Recent deals and strategic collaborations
Strategic Partnerships
Jiangxi IMM was authorized to conduct six studies on the quality standards of traditional Chinese medicine formula granules (including Isatis Root Granule, Epimedium, Sophora Flavescens, Ginseng, Angelica, and Astragalus) to support product quality and R&D.
Terms: Payment terms unspecified; Universe Pharmaceuticals provides related materials and samples.
Collaborative study on the chemical constituents of Liparis Odorata, a traditional Chinese medicine, for the treatment of hyperlipidemia.
Terms: Terms unspecified